Pre Market Engagement for Microbiology Molecular Platforms, Consumables and Quality Control Products

Description

Purpose of the PME: The purpose of this Preliminary Market Engagement (PME) is to seek engagement with the market place on behalf of Belfast, Northern, Southern, South Eastern and Western Health and Social Care Trusts for Northern Ireland to obtain a view of the market’s ability to assist with Microbiology Molecular Platforms, Consumables and Quality Control Products. Supplier Engagement Session: Suppliers are invited to participate at an in person Supplier Engagement Session (SES) to help inform the development of the forthcoming procurement competition, which may be structured either as a fully managed service to one supplier or a model allowing a structure awarding the contract to a multi-lot contract that could be awarded to multiple suppliers. Background: There is a contract currently in place from 30/01/2019-28/02/2028 and the last time the buyers engaged with market was 2017. The value of this current contract is between £35,000,000 - £40,000,000. Information sought from Suppliers: Suppliers participating in the SES should provide a high level overview of current market available capabilities relevant to the test areas included but not limited to those listed below to discuss system functionality, laboratory workflows, and middleware/connectivity considerations, platform capabilities in principle: List of Tests Under Consideration (including but not limited to): 1a. Enteric Pathogens - Molecular Batch Testing Campylobacter, Cryptosporidium & Giardia, Salmonella, Shigella and VTEC 1b. Molecular Batch Testing Clostridium Difficile Toxin PCR 1c. Detection of Vero-Toxin genes producing E-coli 1d. Enteric Virology- Molecular Batch Testing Adenovirus, Rotavirus, Sapovirus, Astrovirus and Norovirus G1 + G2 2a. Moleculcar Batch Testing of Chlamydia & Gonorrhoea PCR 2b. Confirmatory Random Access Testing for Chlamydia & Gonorrhoea PCR 3 Molecular Batch Testing CoVID/Flu & RSV PCR 4 Random Access Testing of COVID/Flu & RSV PCR 5 Random Access MTB and Rifampicin resistance PCR 6 Random Access Testing MRSA PCR 7 Random Access Testing Norovirus PCR 8 Molecular Batch Testing of Trichomonas Vaginalis/Mycoplasma Genitalium (TV/MT) PCR 9 Random Access testing of Mycoplasma Genitalium (MG) with resistance to Azithromycin PCR 10 Random Access Testing of Carbapenamase PCR 11 Random Access Testing Clostridium Difficile Toxin PCR 12 Point of Care Systems for testing of respiratory viruses *Suppliers should note that the list of test areas provided is indicative only and is not exhaustive. The final scope of tests will be determined during the development of the procurement documentation.